ReBlood Rx


ReBlood Rx is dedicated to innovating oxygen therapy through hemoglobin-based solutions, aiming to provide a safe, effective, and reliable oxygen delivery system in medical emergencies where blood transfusions are not an option. Their mission focuses on improving patient outcomes in critical care settings and addressing the challenges of blood supply shortages in both human and veterinary medicine.

ReBlood Rx

ReBlood Rx


What We Do

Hemoglobin-based Oxygen Carrier (HBOC)

A safe, efficient, and universally compatible solution to oxygen delivery in diverse medical scenarios, filling critical gaps in emergency care, surgical procedures, and remote healthcare.


Battlefield Resuscitation


Key People

Carlos Munoz

Co-founder & CEO

LinkedIn

Chris Caballero

Co-founder

LinkedIn

Pedro Cabrales, PhD

Scientific Advisor

LinkedIn

Mark Hughes, DVM, MS

Regulatory Advisor

LinkedIn

Ivan Pires, PhD

Manufacturing Advisor

LinkedIn

News & Updates

ReBlood Rx is excited to enter the last quarter of the year, working diligently to bring their innovation to the world. They express gratitude to Tina Bova for connecting them with Madigan Army Medical Center, which will support their future efforts.

ReBlood Rx thanks the Center for Veterinary Medicine for granting an ADUFA Fee Waiver, saving over $900,000, and shares updates on their participation in various programs and events.

FDA Fee Waiver

ReBlood Rx received an ADUFA Fee Waiver from the Center for Veterinary Medicine, saving over $900,000, promoting innovation in veterinary medicine.

Participation in 757 Accelerate

CEO Carlos Munoz participated in the 757 Accelerate program, preparing to pitch to various Angel groups in October.